Skip to main content
. 2021 Sep 28;12:698236. doi: 10.3389/fimmu.2021.698236

Figure 6.

Figure 6

The value of m6A-predictive score to predict patients’ clinical outcomes with immunotherapy. (A) Comparison of IPS scores between low and high m6A-score groups in meta-GEO and TCGA cohorts. (B) The distribution of CTLA-4 expression levels between low and high m6A-score groups in meta-GEO cohort. The distribution of PD-1 expression levels between low and high m6A-score groups in GSE72094 cohort. (C) The Spearman correlation analysis of CTLA-4 and predictive score in meta-GEO cohort. The Spearman correlation analysis of PD-1 and predictive score in GSE72094 cohort. (D) Kaplan-Meier curves for low and high m6A-score groups in Gide et al. (49) cohort. (E) Kaplan-Meier curves for low and high m6A-score groups in Lauss et al. (50) cohort.